{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:56:56Z","timestamp":1775761016140,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12889-017-4210-2","type":"journal-article","created":{"date-parts":[[2017,4,11]],"date-time":"2017-04-11T00:24:42Z","timestamp":1491870282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":216,"title":["Effectiveness of needle and syringe Programmes in people who inject drugs \u2013 An overview of systematic reviews"],"prefix":"10.1186","volume":"17","author":[{"given":"Ricardo M","family":"Fernandes","sequence":"first","affiliation":[]},{"given":"Maria","family":"Cary","sequence":"additional","affiliation":[]},{"given":"Gon\u00e7alo","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Gon\u00e7alo","family":"Jesus","sequence":"additional","affiliation":[]},{"given":"Joana","family":"Alarc\u00e3o","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Torre","sequence":"additional","affiliation":[]},{"given":"Suzete","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio Vaz","family":"Carneiro","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,4,11]]},"reference":[{"key":"4210_CR1","volume-title":"UNAIDS: the gap report","author":"UNAIDS","year":"2014","unstructured":"UNAIDS: UNAIDS: the gap report. 2014."},{"key":"4210_CR2","volume-title":"Guidance on prevention of viral hepatitis B and c among people who inject drugs","author":"WHO","year":"2007","unstructured":"WHO. Guidance on prevention of viral hepatitis B and c among people who inject drugs. Geneva: WHO; 2007."},{"key":"4210_CR3","first-page":"119","volume":"23","author":"C Torre","year":"2009","unstructured":"Torre C. Syringe exchange Programmes in the context of harm reduction. Arq Med. 2009;23:119\u201331.","journal-title":"Arq Med"},{"key":"4210_CR4","first-page":"170","volume":"113 Suppl","author":"AL Ball","year":"1998","unstructured":"Ball AL, Rana S, Dehne KL. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Rep. 1998;113 Suppl:170\u201381.","journal-title":"Public Health Rep"},{"key":"4210_CR5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2105\/AJPH.79.10.1355","volume":"79","author":"JA Hoek van den","year":"1989","unstructured":"van den Hoek JA, van Haastrecht HJ, Coutinho RA. Risk reduction among intravenous drug users in Amsterdam under the influence of AIDS. Am J Public Health. 1989;79:1355\u20137.","journal-title":"Am J Public Health"},{"key":"4210_CR6","volume-title":"Developing and evaluating complex interventions: new guidance","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: new guidance. London: Medical Research Council; 2008."},{"key":"4210_CR7","volume-title":"European drug report: data and statistics","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2015","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). European drug report: data and statistics. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2015."},{"key":"4210_CR8","unstructured":"The Pharmacy Guild of Australia: Community pharmacy roadmap program development template. Needle and syringe program. 2010; Barton: The Pharmacy Guild of Australia."},{"key":"4210_CR9","volume-title":"Syringe exchange programs around the world: global context","author":"Gay Men\u2019s Health Crisis","year":"2009","unstructured":"Gay Men\u2019s Health Crisis. Syringe exchange programs around the world: global context. New York: Gay Men\u2019s Health Crisis; 2009."},{"key":"4210_CR10","volume-title":"Needle and syringe Programmes, NICE public health guidance","author":"National Institute for Health and Care Excellence (NICE)","year":"2014","unstructured":"National Institute for Health and Care Excellence (NICE). Needle and syringe Programmes, NICE public health guidance, vol. 52. London: National Institute for Health and Care Excellence; 2014."},{"key":"4210_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-2-1","volume":"2","author":"J Sheridan","year":"2005","unstructured":"Sheridan J, Henderson C, Greenhill N, Smith A. Pharmacy-based needle exchange in New Zealand: a review of services. Harm Reduct J. 2005;2:1\u20139.","journal-title":"Harm Reduct J"},{"key":"4210_CR12","unstructured":"Jones L, Pickering L, Sumnall H, Mcveigh J, Mark A, Bellis M. A review of the effectiveness and cost-effectiveness of needle and syringe Programmes for injecting drug users. 2008, Liverpool: Centre for Public Health, Liverpool John Moores University."},{"key":"4210_CR13","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1360-0443.2009.02888.x","volume":"105","author":"N Palmateer","year":"2010","unstructured":"Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction. 2010;105:844\u201359.","journal-title":"Addiction"},{"key":"4210_CR14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","volume":"25","author":"GJ MacArthur","year":"2014","unstructured":"MacArthur GJ, van Velzen E, Palmateer N, Kimber J, Pharris A, Hope V, Taylor A, Roy K, Aspinall E, Goldberg D, Rhodes T, Hedrich D, Salminen M, Hickman M, Hutchinson SJ. Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. Int J Drug Policy. 2014;25:34\u201352.","journal-title":"Int J Drug Policy"},{"key":"4210_CR15","unstructured":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from http:\/\/handbook.cochrane.org\/ ."},{"key":"4210_CR16","volume-title":"Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care","author":"Centre for Reviews and Dissemination","year":"2008","unstructured":"Centre for Reviews and Dissemination. Systematic reviews: CRD\u2019s guidance for undertaking reviews in health care. York: Centre for Reviews and Dissemination, University of York; 2008."},{"key":"4210_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"4210_CR18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"4210_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","volume":"69","author":"P Whiting","year":"2016","unstructured":"Whiting P, Savovi\u0107 J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225\u201334.","journal-title":"J Clin Epidemiol"},{"key":"4210_CR20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"4210_CR21","first-page":"264","volume":"24","author":"I Takacs","year":"2009","unstructured":"Takacs I, Demetrovics Z. The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users. Psychiatr Hung. 2009;24:264\u201381.","journal-title":"Psychiatr Hung"},{"key":"4210_CR22","first-page":"286","volume":"54","author":"M De Lima","year":"2005","unstructured":"De Lima M, Justo L, Formigoni M. Needle exchange in Sao Paulo city: a harm reduction strategy for injection drug users. J Bras Psiquiatr. 2005;54:286\u201392.","journal-title":"J Bras Psiquiatr"},{"key":"4210_CR23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.drugpo.2010.02.001","volume":"21","author":"L Jones","year":"2010","unstructured":"Jones L, Pickering L, Sumnall H, McVeigh J, Bellis MA. Optimal provision of needle and syringe programmes for injecting drug users: a systematic review. Int J Drug Policy. 2010;21:335\u201342.","journal-title":"Int J Drug Policy"},{"key":"4210_CR24","volume-title":"Preventing HIV Infecrtion among injecting drug users in high risk countries: an assessment of the evidence","author":"H Tilson","year":"2006","unstructured":"Tilson H, Aramrattana A, Bozzette S, Celentano D, Falco M, Hammett T. Preventing HIV Infecrtion among injecting drug users in high risk countries: an assessment of the evidence. Washington: Institute of Medicine of the National Academies; 2006."},{"key":"4210_CR25","volume-title":"The effectiveness of needle exchange programs in modifying HIV-related outcomes: a systematic review of the evidence 1997\u20131999","author":"L Leonard","year":"1999","unstructured":"Leonard L, Forrester L, Navarro C, Hansen J, Doucet C. The effectiveness of needle exchange programs in modifying HIV-related outcomes: a systematic review of the evidence 1997\u20131999. Hamilton: Effective Public Health Practice Project (EPHPP); 1999."},{"key":"4210_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1004398707484","volume":"32","author":"J Cross","year":"1998","unstructured":"Cross J, Saunders CM, Bartelli D. The effectiveness of educational and needle exchange programs: a meta-analysis of HIV prevention strategies for injecting drug users. Qual Quant. 1998;32:165\u201380.","journal-title":"Qual Quant"},{"key":"4210_CR27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","volume":"43","author":"E Aspinall","year":"2014","unstructured":"Aspinall E, Nambiar D, Goldberg D, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in hiv transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43:235\u201348.","journal-title":"Int J Epidemiol"},{"key":"4210_CR28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1471-2458-13-53","volume":"13","author":"DC Des Jarlais","year":"2013","unstructured":"Des Jarlais DC, Feelemyer JP, Modi SN, Abdul-Quader A, Hagan H. High coverage needle\/syringe programs for people who inject drugs in low and middle income countries: a systematic review. BMC Public Health. 2013;13:53.","journal-title":"BMC Public Health"},{"key":"4210_CR29","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1007\/s10461-013-0593-y","volume":"17","author":"AS Abdul-Quader","year":"2013","unstructured":"Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, Horvath T, et al. Effectiveness of structural-level needle\/syringe programs to reduce HCV and HIV infection among people who inject drugs: a systematic review. AIDS Behav. 2013;17:2878\u201392.","journal-title":"AIDS Behav"},{"key":"4210_CR30","unstructured":"Kall K, Hermansson U, Amundsen EJ, Ronnback K, Ronnberg S. The Effectiveness of Needle Exchange Programmes for HIV Prevention A Critical Review. J Glob Drug Policy Pract. 2007;1(3). http:\/\/www.globaldrugpolicy.org\/Issues\/Vol%201%20Issue%203\/The%20Effectiveness%20of%20Needle%20Exchange.pdf . Accessed 20 Aug 2015."},{"key":"4210_CR31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10461-008-9483-0","volume":"13","author":"Y Hong","year":"2009","unstructured":"Hong Y, Li X. HIV\/AIDS behavioral interventions in China: a literature review and recommendation for future research. AIDS Behav. 2009;13:603\u201313.","journal-title":"AIDS Behav"},{"key":"4210_CR32","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","volume":"106","author":"KME Turner","year":"2011","unstructured":"Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106:1978\u201388.","journal-title":"Addiction"},{"key":"4210_CR33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7517-3-27","volume":"3","author":"NMJ Wright","year":"2006","unstructured":"Wright NMJ, Tompkins CNE. A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users. Harm Reduct J. 2006;3:27.","journal-title":"Harm Reduct J"},{"key":"4210_CR34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/infdis\/jir196","volume":"204","author":"H Hagan","year":"2011","unstructured":"Hagan H, Pouget ER, Des Jarlais DC. A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs. J Infect Dis. 2011;204:74\u201383.","journal-title":"J Infect Dis"},{"key":"4210_CR35","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200107270-00002","volume":"15","author":"DR Gibson","year":"2001","unstructured":"Gibson DR, Flynn NM, Perales D. Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS. 2001;15:1329\u201341.","journal-title":"AIDS"},{"key":"4210_CR36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jurban\/79.2.257","volume":"79","author":"CL Miller","year":"2002","unstructured":"Miller CL, Tyndall M, Spittal P, Li K, Palepu A, Schechter MT. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges. J Urban Health. 2002;79:257\u201365.","journal-title":"J Urban Health"},{"key":"4210_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/01459740.1997.9966152","volume":"18","author":"M Singer","year":"1997","unstructured":"Singer M, Himmelgreen D, Weeks MR, Radda KE, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CTs. Med Anthropol. 1997;18:107\u201330.","journal-title":"Med Anthropol"},{"key":"4210_CR38","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","volume":"102","author":"C Van Den Berg","year":"2007","unstructured":"Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam cohort studies among drug users. Addiction. 2007;102:1454\u201362.","journal-title":"Addiction"},{"key":"4210_CR39","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/oxfordjournals.aje.a009240","volume":"146","author":"J Bruneau","year":"1997","unstructured":"Bruneau J, Lamothe F, Franco E, Lachance N, D\u00e9sy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study. Am J Epidemiol. 1997;146:994\u20131002.","journal-title":"Am J Epidemiol"},{"key":"4210_CR40","doi-asserted-by":"crossref","first-page":"f59","DOI":"10.1097\/00002030-199708000-00001","volume":"11","author":"S Strathdee","year":"1997","unstructured":"Strathdee S, Patrick D, Currie S, Cornelisse P, Rekart M, Montaner J, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11:f59\u201365.","journal-title":"AIDS"},{"key":"4210_CR41","volume-title":"What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity","author":"N Wright","year":"2005","unstructured":"Wright N, Millson C. What is the evidence for the effectiveness of interventions to reduce hepatitis C infection and the associated morbidity. Copenhagen: World Health Organization Europe; 2005."},{"key":"4210_CR42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00126334-200306010-00014","volume":"33","author":"DG Fisher","year":"2003","unstructured":"Fisher DG, Fenaughty AM, Cagle HH, Wells RS. Needle exchange and injection drug use frequency: a randomized clinical trial. J Acquir Immune Defic Syndr. 2003;33:199\u2013205.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4210_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1521\/aeap.2007.19.2.97","volume":"19","author":"C Masson","year":"2007","unstructured":"Masson C, Sorensen J, Perlman D, Shopshire M, Delucchi K, Chen T, et al. Hospital- versus community-based syringe exchange: a randomized controlled trial. AIDS Educ Prev. 2007;19:97\u2013100.","journal-title":"AIDS Educ Prev"},{"key":"4210_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.socscimed.2007.08.022","volume":"66","author":"J Cox","year":"2008","unstructured":"Cox J, De P, Morissette C, Tremblay C, Stephenson R, Allard R, et al. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users. Soc Sci Med. 2008;66:211\u201320.","journal-title":"Soc Sci Med"},{"key":"4210_CR45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jsat.2006.11.002","volume":"32","author":"KG Heinzerling","year":"2007","unstructured":"Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. J Subst Abus Treat. 2007;32:423\u20139.","journal-title":"J Subst Abus Treat"},{"key":"4210_CR46","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.drugpo.2003.07.002","volume":"14","author":"AH Kral","year":"2003","unstructured":"Kral AH. What is it about needle and syringe programmes that make them effective for preventing HIV transmission? Int J Drug Policy. 2003;14:361\u20133.","journal-title":"Int J Drug Policy"},{"key":"4210_CR47","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.drugpo.2005.07.003","volume":"16","author":"W Small","year":"2005","unstructured":"Small W. Examining barriers to syringe access among injection drug users. Int J Drug Policy. 2005;16:291\u20132.","journal-title":"Int J Drug Policy"},{"key":"4210_CR48","volume-title":"Policy guidelines for collaborative TB and HIV Services for Injecting and Other Drug Users \u2013 an integrated approach","author":"WHO","year":"2008","unstructured":"WHO. Policy guidelines for collaborative TB and HIV Services for Injecting and Other Drug Users \u2013 an integrated approach. Geneva: World Health Organization, United Nations Office on Drugs and Crime; 2008."},{"key":"4210_CR49","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/BF02386743","volume":"77","author":"P Coffin","year":"2000","unstructured":"Coffin P. Syringe availability as HIV prevention: a review of modalities. J Urban Health. 2000;77:306\u201330.","journal-title":"J Urban Health"},{"key":"4210_CR50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000050713","volume":"7","author":"JP Moatti","year":"2001","unstructured":"Moatti JP, Vlahov D, Feroni I, Perrin V, Obadia Y. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France. Eur Addict Res. 2001;7:40\u20135.","journal-title":"Eur Addict Res"},{"key":"4210_CR51","volume-title":"Harm reduction overview for Ireland","author":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2016","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Harm reduction overview for Ireland. Lisbon: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2016."},{"key":"4210_CR52","unstructured":"Programa de Intercambio de Jeringuillas, Pa\u00eds Vasco. http:\/\/www.observatoriocarteraservicios.com\/iniciativas\/programa-de-intercambio-de-jeringuillas-pais-vasco# . Accessed 29 Dec 2015."},{"key":"4210_CR53","unstructured":"NHS England: Improving Health and Patient Care through Community Pharmacy - Evidence Resource Pack. 2013; London. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/12\/comm-pharm-res-pack.pdf . Accessed 29 Dec 2015."},{"key":"4210_CR54","unstructured":"Community Pharmacy Contract - Enhanced Services. http:\/\/www.wales.nhs.uk\/sites3\/page.cfm?orgid=498&pid=7552 . Accessed 29 Dec 2015."},{"key":"4210_CR55","unstructured":"NHS Care Services. Local Services. http:\/\/www.communitypharmacyscotland.org.uk\/nhs-care-services\/services\/local-services\/ . Accessed 29 Dec 2015."},{"key":"4210_CR56","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ebch.1968","volume":"9","author":"L Hartling","year":"2014","unstructured":"Hartling L, Vandermeer B, Fernandes RM. Systematic reviews, overviews of reviews and comparative effectiveness reviews: a discussion of approaches to knowledge synthesis. Evid-Based Child Heal. 2014;9:486\u201394.","journal-title":"Evid-Based Child Heal"},{"key":"4210_CR57","doi-asserted-by":"crossref","unstructured":"Hartling L, Chisholm A, Thomson D, Dryden DM. A descriptive analysis of overviews of reviews published between 2000 and 2011. PLoS One. 2012;7:e49667. http:\/\/dx.doi.org\/10.1371\/journal.pone.0049667 .","DOI":"10.1371\/journal.pone.0049667"},{"key":"4210_CR58","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jclinepi.2012.06.015","volume":"65","author":"D Pieper","year":"2012","unstructured":"Pieper D, Buechter R, Jerinic P, Eikermann M. Overviews of reviews often have limited rigor: a systematic review. J Clin Epidemiol. 2012;65:1267\u201373.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-017-4210-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:37:04Z","timestamp":1498387024000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-017-4210-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,11]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4210"],"URL":"https:\/\/doi.org\/10.1186\/s12889-017-4210-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,11]]},"article-number":"309"}}